Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAminex Regulatory News (AEX)

Share Price Information for Aminex (AEX)

Share Price is delayed by 15 minutes
Get Live Data
2.625    -0.05 (-1.85%)
Bid:
2.60
Ask:
2.65
Spread: 0.05 (1.923%)
Market Cap: £118.59m
AEX Live PriceLast checked at - London Stock Exchange

Intraday Aminex Share Chart

Directorate Changes

14 May 2020 10:00

RNS Number : 9072M
Aminex PLC
14 May 2020
 

14 May 2020

 

Aminex plc

("Aminex" or "the Company")

 

 

DIRECTORATE CHANGES

 

Aminex is pleased to announce the appointments of Mr Harald van Dongen and Mr Jan Gunnar Opsal, as Non-Executive Directors of the Company with immediate effect. Mr Opsal will replace Mr Ola Fjeld, who steps down as a Non-Executive Director after almost four years on the Board, also with immediate effect.

Under the terms of the Shareholder and Relationship Agreement dated 8 July 2016, Eclipse Investments LLC ("Eclipse") has the right to appoint two directors to the Aminex Board ("Eclipse Directors"). Mr van Dongen and Mr Opsal will be proposed for election by shareholders at the next General Meeting of the Company. Assuming that the shareholders approve the election of Mr van Dongen and Mr Opsal at the next General Meeting of the Company, Eclipse will (as in previous years) receive an annual directors' fee of £35,000 for each of the Eclipse Directors. Historically, Eclipse has applied such fee towards reimbursement of the travel, accommodation and other costs incurred by it in connection with the Eclipse Directors' travel, etc in the discharge of their responsibilities to the Company. Such fee has not been increased since 1 January 2018. Eclipse will not seek share options for either of the Eclipse Directors.

Mr Opsal is currently the General Manager of ARA Norway Invest, an associate company of Eclipse and The Zubair Corporation, which focusses on investing in innovative petroleum technology. Mr Opsal is also founder and Chief Executive Officer of Searcher Geoservices in Norway. He has a MSc in Geophysics and has over 20 years' experience in the international oil and gas industry, during which time he has worked for Equinor, Det norske oljeselskap and Weatherford. Mr Opsal has been involved in several Field Development Plans during his career. He was a Board Member of Det norske oljeselskap (now Aker BP) at the time of its IPO on the Oslo Stock Exchange.

Mr van Dongen is currently Value Assurance Manager of ARA Petroleum LLC ("ARA"), an associate company of Eclipse and The Zubair Corporation. He is a Dutch national and has been active in the international oil and gas industry since 1995. His career started with Shell International holding various subsurface positions and continued with Total SA in a business development role covering the Far East. Before joining ARA in 2014 as Value Assurance manager he worked as an Asset Development Manager for OMV Petrom and Tulip Oil. At ARA Mr van Dongen is responsible for upstream M&A, economic, financial portfolio and performance management. He holds a MSc in Applied Physics and an MBA in Financial Risk Management.

Aminex confirms that there are no matters requiring disclosure in respect of this appointment under paragraph LR9.6.13R of the Listing Rules of the Financial Conduct Authority.

Aminex Chairman John Bell commented:

"We warmly welcome Harald and Jan Gunnar to the Board of Aminex and look forward to working with them. We have known Harald for many years, and he has supported Aminex's strategic initiatives in the past. As Aminex moves to the next phase both Harald and Jan Gunnar bring a wealth of experience and capability that strengthens and complements the Board. These skills will be extremely beneficial as Aminex charts and delivers the next chapter of its strategic development while maintaining a low-cost management structure.

On behalf of the Board, we thank Ola for his contribution to the Company over the last four years and look forward to working with him as ARA Petroleum Tanzania develops the Ruvuma gas field. In the meantime, we all wish him well for the future."

 

 

For further information:

 

Aminex PLC

 

+44 20 3198 8415

John Bell, Chairman

Robert Ambrose, Chief Executive Officer

Davy

+353 1 679 6363

Brian Garrahy

Camarco

+44 20 3781 8331

Billy Clegg / James Crothers / Daniel Sherwen

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAPSLFSXEEEA
Date   Source Headline
18th Aug 202110:00 amRNSExtension of Ruvuma Licence
29th Jul 20213:04 pmRNSResult of AGM
28th Jul 20217:00 amRNSDirectorate Change and Update on AGM
7th Jul 20217:00 amRNSNotice of AGM
30th Jun 20215:17 pmRNSRuvuma Operations Update
30th Jun 20215:15 pmRNSFinal Results
28th May 20214:37 pmRNSUpdate to Annual Report and Accounts deadline
29th Apr 20214:36 pmRNSPrice Monitoring Extension
29th Apr 20217:00 amRNSExtension to Annual Report and Accounts deadline
1st Apr 202111:05 amRNSSecond Price Monitoring Extn
1st Apr 202111:00 amRNSPrice Monitoring Extension
29th Mar 20219:05 amRNSSecond Price Monitoring Extn
29th Mar 20219:00 amRNSPrice Monitoring Extension
26th Mar 20212:05 pmRNSSecond Price Monitoring Extn
26th Mar 20212:00 pmRNSPrice Monitoring Extension
26th Mar 202111:05 amRNSSecond Price Monitoring Extn
26th Mar 202111:00 amRNSPrice Monitoring Extension
25th Mar 20214:41 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
25th Mar 20212:05 pmRNSSecond Price Monitoring Extn
25th Mar 20212:00 pmRNSPrice Monitoring Extension
11th Mar 20214:48 pmRNSUpdate on migration of shares from CREST
11th Mar 20214:41 pmRNSSecond Price Monitoring Extn
11th Mar 20214:35 pmRNSPrice Monitoring Extension
10th Mar 20217:00 amRNSRuvuma Operations Update
18th Feb 20211:06 pmRNSResult of EGM
29th Jan 20217:00 amRNSStrategic and Corporate Update
27th Jan 20217:00 amRNSNotice of EGM
26th Jan 202110:00 amRNSDirectorate Change
7th Jan 202111:06 amRNSSecond Price Monitoring Extn
7th Jan 202111:01 amRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:37 pmRNSPrice Monitoring Extension
22nd Dec 20204:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20204:36 pmRNSPrice Monitoring Extension
22nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
22nd Dec 20202:00 pmRNSPrice Monitoring Extension
22nd Dec 202011:06 amRNSSecond Price Monitoring Extn
22nd Dec 202011:00 amRNSPrice Monitoring Extension
8th Dec 20204:41 pmRNSSecond Price Monitoring Extn
8th Dec 20204:36 pmRNSPrice Monitoring Extension
8th Dec 20202:05 pmRNSSecond Price Monitoring Extn
8th Dec 20202:00 pmRNSPrice Monitoring Extension
8th Dec 202011:05 amRNSSecond Price Monitoring Extn
8th Dec 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20204:40 pmRNSSecond Price Monitoring Extn
23rd Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20202:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20202:00 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.